ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895,349 | -30.5% | 32,990 | -21.3% | 0.01% | -41.2% |
| Q2 2023 | $1,288,160 | +94.5% | 41,905 | +127.9% | 0.02% | +88.9% |
| Q1 2023 | $662,376 | -47.9% | 18,384 | -42.9% | 0.01% | -55.0% |
| Q4 2022 | $1,271,833 | -7.3% | 32,182 | -52.9% | 0.02% | +25.0% |
| Q3 2022 | $1,372,371 | +266.0% | 68,256 | +665.8% | 0.02% | +128.6% |
| Q2 2022 | $375,000 | -79.3% | 8,913 | -80.8% | 0.01% | -68.2% |
| Q1 2022 | $1,808,000 | +146.3% | 46,413 | +128.6% | 0.02% | +266.7% |
| Q3 2021 | $734,000 | -45.8% | 20,299 | -38.5% | 0.01% | -50.0% |
| Q2 2021 | $1,353,000 | +430.6% | 33,000 | +463.7% | 0.01% | +300.0% |
| Q1 2021 | $255,000 | – | 5,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |